Xero Limited Price Chart
Xero Limited XRO.XA Financial and Trading Overview
| Xero Limited stock price | 121.17 AUD |
| Previous Close | 113.69 AUD |
| Open | 113.99 AUD |
| Bid | 0 AUD x N/A |
| Ask | 0 AUD x N/A |
| Day's Range | 113.99 - 118.33 AUD |
| 52 Week Range | 62.87 - 118.33 AUD |
| Volume | 123.74K AUD |
| Avg. Volume | 49.51K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.944061 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.056 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
XRO.XA Valuation Measures
| Enterprise Value | 16.82B AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 16.770006 |
| Enterprise Value/Revenue | 12.012 |
| Enterprise Value/EBITDA | 159.079 |
Trading Information
Xero Limited Stock Price History
| Beta (5Y Monthly) | 0.944061 |
| 52-Week Change | 54.34% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 118.33 AUD |
| 52 Week Low | 62.87 AUD |
| 50-Day Moving Average | 98.68 AUD |
| 200-Day Moving Average | 82.46 AUD |
XRO.XA Share Statistics
| Avg. Volume (3 month) | 49.51K AUD |
| Avg. Daily Volume (10-Days) | 68.86K AUD |
| Shares Outstanding | N/A |
| Float | 137.26M |
| Short Ratio | N/A |
| % Held by Insiders | 15.98% |
| % Held by Institutions | 26.26% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | -8.10% |
| Operating Margin (ttm) | 6.57% |
| Gross Margin | 87.28% |
| EBITDA Margin | 7.55% |
Management Effectiveness
| Return on Assets (ttm) | 2.37% |
| Return on Equity (ttm) | -10.87% |
Income Statement
| Revenue (ttm) | 1.4B AUD |
| Revenue Per Share (ttm) | 9.33 AUD |
| Quarterly Revenue Growth (yoy) | 25.39% |
| Gross Profit (ttm) | N/A |
| EBITDA | 105.7M AUD |
| Net Income Avi to Common (ttm) | -113532000 AUD |
| Diluted EPS (ttm) | -0.056 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.12B AUD |
| Total Cash Per Share (mrq) | 7.4 AUD |
| Total Debt (mrq) | 1.14B AUD |
| Total Debt/Equity (mrq) | 108.47 AUD |
| Current Ratio (mrq) | 4.954 |
| Book Value Per Share (mrq) | 6.978 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 390.45M AUD |
| Levered Free Cash Flow (ttm) | 124.48M AUD |
Profile of Xero Limited
| Country | Australia |
| State | N/A |
| City | Wellington |
| Address | Xero One |
| ZIP | 6011 |
| Phone | N/A |
| Website | https://www.xero.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 5080 |
Xero Limited, together with its subsidiaries, operates as a software as a service company in New Zealand, Australia, the United Kingdom, and internationally. The company offers Xero, an open platform that connects small businesses to a range of solutions, which helps to manage their finances. It also provides Xero mobile app; and accountant/bookkeeper tools, including Xero HQ, Xero Practice Manager, Xero Workpapers, and Xero Cashbook or Xero Ledger. Xero Limited was incorporated in 2006 and is headquartered in Wellington, New Zealand.
Q&A For Xero Limited Stock
What is a current XRO.XA stock price?
Xero Limited XRO.XA stock price today per share is 121.17 AUD.
How to purchase Xero Limited stock?
You can buy XRO.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Xero Limited?
The stock symbol or ticker of Xero Limited is XRO.XA.
How many shares does Xero Limited have in circulation?
The max supply of Xero Limited shares is 0.
What is Xero Limited Price to Earnings Ratio (PE Ratio)?
Xero Limited PE Ratio is now.
What was Xero Limited earnings per share over the trailing 12 months (TTM)?
Xero Limited EPS is -0.056 AUD over the trailing 12 months.